EconBiz - Find Economic Literature
    • Logout
    • Change account settings
  • A-Z
  • Beta
  • About EconBiz
  • News
  • Thesaurus (STW)
  • Academic Skills
  • Help
  •  My account 
    • Logout
    • Change account settings
  • Login
EconBiz - Find Economic Literature
Publications Events
Search options
Advanced Search history
My EconBiz
Favorites Loans Reservations Fines
    You are here:
  • Home
  • Search: subject_exact:"Pharmacology"
Narrow search

Narrow search

Year of publication
Subject
All
Pharmacology 1,279 Pharmakologie 1,276 Pharmaceutical industry 740 Pharmaindustrie 740 Arzneimittel 710 Pharmaceuticals 707 Innovation 384 Arzneimittelmarkt 226 Pharmaceutical market 218 USA 187 United States 184 Welt 167 World 167 Patent 150 Theorie 125 Theory 125 Industrieforschung 117 Industrial research 115 Hospital 92 Innovationsmanagement 92 Krankenhaus 92 Innovation management 89 Gesundheitswesen 87 Health care system 85 Biotechnologie 83 Biotechnology 82 Gesundheitspolitik 81 Immaterialgüterrechte 79 Intellectual property rights 79 Technologiepolitik 77 Technology policy 77 Health care 75 Gesundheitsversorgung 74 Arzneimittelrecht 73 Health policy 72 Pharmaceutical law 71 Pharmazeutische Industrie 69 Gesundheitskosten 68 Health care costs 68 Medizin 68
more ... less ...
Online availability
All
Free 480 Undetermined 272 CC license 20
Type of publication
All
Book / Working Paper 704 Article 579 Journal 10 Other 1
Type of publication (narrower categories)
All
Article in journal 417 Aufsatz in Zeitschrift 417 Graue Literatur 264 Non-commercial literature 264 Working Paper 224 Arbeitspapier 222 Aufsatz im Buch 115 Book section 115 Hochschulschrift 46 Thesis 40 Collection of articles of several authors 31 Sammelwerk 31 Case study 22 Fallstudie 22 Aufsatzsammlung 13 Konferenzschrift 10 Amtsdruckschrift 7 Government document 7 Conference proceedings 6 Advisory report 4 Gutachten 4 Bibliografie enthalten 3 Bibliography included 3 Collection of articles written by one author 3 Lehrbuch 3 Sammlung 3 Amtliche Publikation 2 Bibliografie 2 Glossar enthalten 2 Glossary included 2 Handbook 2 Handbuch 2 Market information 2 Marktinformation 2 Rezension 2 Statistics 2 Statistik 2 Textbook 2 research-article 2 Abstract 1
more ... less ...
Language
All
English 1,192 German 77 French 8 Italian 7 Undetermined 3 Portuguese 2 Spanish 2 Danish 1 Polish 1 Russian 1 Swedish 1
more ... less ...
Author
All
Lichtenberg, Frank R. 43 Lo, Andrew W. 22 Philipson, Tomas J. 15 Williams, Heidi 15 Berndt, Ernst R. 14 Snyder, Christopher M. 14 Kremer, Michael 13 Thakor, Richard T. 13 Cockburn, Iain 12 Higgins, Matthew J. 12 Kyle, Margaret K. 12 Rake, Bastian 11 Reepmeyer, Gerrit 11 Vernon, John A. 11 Henderson, Rebecca 10 Veugelers, Reinhilde 9 Chatterjee, Chirantan 8 Cutler, David M. 8 Lanjouw, Jean Olson 8 Ouellette, Lisa Larrimore 8 Banerjee, Tannista 7 Budish, Eric B. 7 Durvasula, Maya 7 Finkelstein, Amy 7 Li, Danielle 7 Roin, Benjamin N. 7 Siebert, Ralph 7 Sood, Neeraj 7 Tian, Zhili 7 Bhalotra, Sonia 6 Chick, Stephen E. 6 Gassmann, Oliver 6 Glennerster, Rachel 6 Jørring, Adam 6 Malek, Jan 6 Sampat, Bhaven N. 6 Seldeslachts, Jo 6 Singh, Manita 6 Stargardt, Tom 6 Bhattacharya, Jay 5
more ... less ...
Institution
All
National Bureau of Economic Research 63 OECD 4 Fraunhofer-Institut für System- und Innovationsforschung 3 Council of the European Union / General Secretariat of the Council of the European Union 2 Edward Elgar Publishing 2 European Commission / Joint Research Centre 2 Europäisches Parlament / Policy Department for Economic, Scientific and Quality of Life Policies 2 Fraunhofer-Institut für Systemtechnik und Innovationsforschung 2 Großbritannien / Ministry of Health 2 Verband Forschender Arzneimittelhersteller 2 American Enterprise Institute for Public Policy Research 1 Bundesverband der Pharmazeutischen Industrie 1 CSIL 1 Centre for European Policy Studies 1 Centro studi investimenti sociali 1 Chemical Heritage Foundation 1 Conference on International Harmonisation of Veterinary Medicinal Products <1, 1999, Brüssel> 1 Ekonomiska forskningsinstitutet <Stockholm> 1 European Commission / Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs 1 European Commission / Directorate-General for Research 1 European Commission / Directorate-General for Research and Innovation 1 European Federation of Animal Health 1 European Monitoring Centre for Drugs and Drug Addiction 1 European Parliament / Directorate-General for Internal Policies of the Union 1 European Parliament / Directorate-General for Parliamentary Research Services 1 Europäische Kommission / Gemeinsame Forschungsstelle 1 Europäische Kommission / Gemeinsame Forschungsstelle / Institut für Technologische Zukunftsforschung 1 Europäische Kommission / Gemeinsame Forschungsstelle / Institut für Technologische Zukunftsforschung / European Science and Technology Observatory 1 Europäische Kommission / Generaldirektion Binnenmarkt, Industrie, Unternehmertum und KMU 1 Europäischer Wirtschafts- und Sozialausschuss 1 Europäisches Parlament / Generaldirektion Wissenschaft / Abteilung Industrie, Forschung, Energie und Umwelt 1 Fraser Institute 1 Friedrich-Schiller-Universität Jena 1 Georgetown University / Economics Department 1 IDEA - Inspire, Debate, Engage and Accelerate Action Consult 1 Independent Institute 1 Institut für Systemtechnik und Innovationsforschung 1 International Association for the Study of Insurance Economics 1 International Society for Pharmacoeconomics and Outcomes Research 1 International Symposium on Industrial Development <1967, Athen> 1
more ... less ...
Published in...
All
NBER working paper series 64 NBER Working Paper 42 Working paper / National Bureau of Economic Research, Inc. 41 Research policy : policy, management and economic studies of science, technology and innovation 32 Research paper 18 Journal of health economics 13 The European journal of health economics : HEPAC ; health economics in prevention and care 11 International journal of pharmaceutical and healthcare marketing : IJPHM 10 Technological forecasting & social change : an international journal 10 CESifo working papers 8 Discussion papers / CEPR 8 Health economics 8 Discussion paper / Centre for Economic Policy Research 7 Jena economics research papers 7 SpringerLink / Bücher 7 Academy of Management journal : AMJ 6 Forum for health economics & policy : an evolving collection of symposia on important health care issues 6 International journal of technology management : IJTM 6 Management science : journal of the Institute for Operations Research and the Management Sciences 6 Bittere Arznei : Wirtschaftsethik und Ökonomik der pharmazeutischen Industrie 5 Darden Case 5 Faculty & research / Insead : working paper series 5 Health affairs : at the intersection of health, health care, and policy 5 Technology analysis & strategic management 5 Working paper series 5 Economics of innovation and new technology 4 Emerging technologies : from hindsight to foresight 4 Health economics review 4 Innovation and marketing in the pharmaceutical industry : emerging practices, research, and policies 4 Innovation: organization & management : IOM 4 International journal of health economics and management 4 International journal of the economics of business 4 Journal of business ethics : JOBE 4 Manufacturing & service operations management : M & SOM 4 Review of industrial organization : RIO 4 The American economic review 4 The European journal of health economics 4 The journal of technology transfer 4 Working paper series / United Nations University, UNU-MERIT 4 Working papers / Harvard Business School, Division of Research 4
more ... less ...
Source
All
ECONIS (ZBW) 1,273 BASE 7 USB Cologne (EcoSocSci) 5 Other ZBW resources 5 EconStor 3 RePEc 1
Showing 1 - 50 of 1,294
Cover Image
The long run economic effects of medical innovation and the role of opportunities
Bhalotra, Sonia; Clarke, Damian; Venkataramani, Atheendar S. - 2026
We leverage the introduction of the first antibiotic therapies in 1937 to examine the long run effects of early childhood pneumonia on adult educational attainment, employment, income, and work-related disability. Using census data, we document large average gains on all outcomes, alongside...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015605518
Saved in:
Cover Image
The long run economic effects of medical innovation and the role of opportunities
Bhalotra, Sonia; Clarke, Damian; Venkataramani, Atheendar S. - 2026
We leverage the introduction of the first antibiotic therapies in 1937 to examine the long-run effects of early childhood pneumonia on adult educational attainment, employment, income, and work-related disability. Using census data, we document large average gains on all outcomes, alongside...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015586904
Saved in:
Cover Image
Timely access to new pharmaceuticals in Canada, the United States, and the European Union, 2026
Acri, Kristina M. L.; Assad, Lauren - Fraser Institute - 2026
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015613516
Saved in:
Cover Image
Improving Rationality by Increasing Attention
Chung, Hui-Kuan; Doren, Nick; Mononen, Lasse; Lu, Mia; … - 2025
Models of limited attention have the potential to become a new unifying paradigm that could replace the rational choice approach. In this paper, we test the limited attention hypothesis by enhancing attention using pharmacological substances. A total of 160 subjects participated in our...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015461462
Saved in:
Cover Image
Pharmaceutical regulation and incentives for innovation in an international perspective
Dubois, Pierre - 2025
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015466930
Saved in:
Cover Image
Disclosure and the pace of drug development
Cunnningham, Colleen; Ederer, Florian; Hodgson, Charles; … - 2025
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015467032
Saved in:
Cover Image
Bedside manner or technical quality? : building advocacy for clinical trial participation via rapport
Mulcahy, Rory; Piplica, Sarah; Fleischman, David - In: Health marketing quarterly 42 (2025) 3, pp. 329-342
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015519581
Saved in:
Cover Image
Competition matters : uniform vs. indication-based pricing of pharmaceuticals
Brekke, Kurt R.; Dalen, Dag Morten; Straume, Odd Rune - 2025
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015463573
Saved in:
Cover Image
Information disclosure and peer innovation : evidence from mandatory reporting of clinical trials
Hsu, Po-Hsuan; Lee, Kyungran; Moon, S. Katie; Oh, Seungjoon - In: Journal of financial and quantitative analysis : JFQA 60 (2025) 7, pp. 3267-3310
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015550407
Saved in:
Cover Image
Improving rationality by increasing attention
Chung, Hui-Kuan; Doren, Nick; Mononen, Lasse; Lu, Mia; … - 2025
Models of limited attention have the potential to become a new unifying paradigm that could replace the rational choice approach. In this paper, we test the limited attention hypothesis by enhancing attention using pharmacological substances. A total of 160 subjects participated in our...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015454002
Saved in:
Cover Image
A review of the literature on the new European Medical Device Regulations requirements for increased clinical evaluation
McDermott, Olivia; Kearney, Breda - In: International journal of pharmaceutical and healthcare … 19 (2025) 1, pp. 1-21
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015419422
Saved in:
Cover Image
Are M&As spurring or stifling innovation? : evidence from antidiabetic drug development
Malek, Jan; Seldeslachts, Jo; Veugelers, Reinhilde - 2025
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015435938
Saved in:
Cover Image
Modelling the global economic impact of antimicrobial resistance in humans
Countryman, Amanda M.; McDonnell, Anthony - 2025
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015405411
Saved in:
Cover Image
Firm-level innovation and the role of political capabilities : evidence for the pharmaceuticals industry
Saha, Amrita; Pozo Segura, Juan Manuel del; Palazzo, Gabriel - 2025
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015405762
Saved in:
Cover Image
Are M&As spurring or stifling innovation? : evidence from antidiabetic drug development
Malek, Jan; Seldeslachts, Jo; Veugelers, Reinhilde - 2025
This paper provides empirical evidence on which M&A deals spur innovation, and which stifle it. To do so, we consider not only the product market position of the acquiring firm, but also the position of both target and acquirer in the technology space. Focusing on the antidiabetic drugs market,...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015434666
Saved in:
Cover Image
Can the size and duration of clinical trials in new drug applications predict post-approval safety warnings?
Clark, Jeremy; Menclova, Andrea Kutinova - 2025
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015394355
Saved in:
Cover Image
Medical research and health care finance : evidence from Academic Medical Centers
Azoulay, Pierre; Heggeness, Misty; Kao, Jennifer L. - In: Research policy : policy, management and economic … 54 (2025) 2, pp. 1-17
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015564644
Saved in:
Cover Image
When the drugs (don't) work : the role of science in product commercialization
Anckaert, Paul-Emmanuel - In: Research policy : policy, management and economic … 54 (2025) 5, pp. 1-18
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015567698
Saved in:
Cover Image
Marketing authorization and strategic patenting : evidence from pharmaceuticals
Byrski, Dennis; Wang, Lucy Xiaolu - In: Journal of public economics 247 (2025), pp. 1-26
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015562837
Saved in:
Cover Image
Barracudas, Piranhas and crowds : making ideas valuable in pharmaceutical innovation through opening and closing practices of valuation
Zangerle, Katharina; Dobusch, Leonhard; Weiskopf, Richard - In: Innovation: organization & management : IOM 27 (2025) 4, pp. 520-537
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015590033
Saved in:
Cover Image
Improving rationality by increasing attention
Chung, Hui-Kuan; Doren, Nick; Mononen, Lasse; Lu, Mia; … - 2025
Models of limited attention have the potential to become a new unifying paradigm that could replace the rational choice approach. In this paper, we test the limited attention hypothesis by enhancing attention using pharmacological substances. A total of 160 subjects participated in our...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015574927
Saved in:
Cover Image
Improving rationality by increasing attention
Chung, Hui-Kuan; Doren, Nick; Mononen, Lasse; Lu, Mia; … - 2025
Models of limited attention have the potential to become a new unifying paradigm that could replace the rational choice approach. In this paper, we test the limited attention hypothesis by enhancing attention using pharmacological substances. A total of 160 subjects participated in our...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015532966
Saved in:
Cover Image
The long run economic effects of medical innovation and the role of opportunities
Bhalotra, Sonia; Clarke, Damian; Venkataramani, Atheendar S. - 2025
We leverage the introduction of the first antibiotic therapies in 1937 to examine the long-run effects of early-childhood pneumonia on adult educational attainment, employment, income, and work-related disability. Using census data, we document large average improvements across all outcomes,...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015557995
Saved in:
Cover Image
Role of global public sector research in discovering new drugs and vaccines
Stevens, Ashley J.; Benson, David E.; Dodson, Sara E.; … - In: The journal of technology transfer 49 (2024) 3, pp. 857-867
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015056452
Saved in:
Cover Image
COVID-19 biopharmaceutical innovation and industry appropriation
Philipson, Tomas J.; Fendrick, A. Mark; Kataria, Aarushi; … - In: Forum for health economics & policy : an evolving … 27 (2024) 2, pp. 117-146
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015436899
Saved in:
Cover Image
Competition and pharmaceutical innovation : the moderating role of size and age of leading companies in the market
Jung, Ye Lim; Yoo, Hyoung Sun - In: IEEE transactions on engineering management : EM ; a … 71 (2024), pp. 3088-3097
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015405937
Saved in:
Cover Image
Health ecosystem : active pharmaceutical ingredients
European Commission / Directorate-General for Internal …; … - 2024
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015275965
Saved in:
Cover Image
Special FDA designations for drug development : orphan, fast track, accelerated approval, priority review, and breakthrough therapy
Michaeli, Daniel; Michaeli, Christoph T.; Albers, Sebastian - In: The European journal of health economics 25 (2024) 6, pp. 979-997
Over the past decades, US Congress enabled the US Food and Drug Administration (FDA) to facilitate and expedite drug development for serious conditions filling unmet medical needs with five special designations and review pathways: orphan, fast track, accelerated approval, priority review, and...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015131485
Saved in:
Cover Image
Setting pharmaceutical drug prices : what the medicare negotiators need to know about innovation and financialization
Tulum, Öner; Lazonick, William - 2024
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015099143
Saved in:
Cover Image
The rise of spin-offs : fueling pharmaceutical innovation through collaboration
Yashiro, Kentaro; Lim, Yeongjoo; Sengoku, Shintaro; … - In: Journal of open innovation : technology, market, and … 10 (2024) 1, pp. 1-11
Collaboration among various organizations is important for the sustainable creation of new innovative drugs. Previously, drug discovery was dominated by large pharmaceutical companies; however, various new players are now actively involved in this endeavor. Nevertheless, the factors affecting...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10014518795
Saved in:
Cover Image
Scientific evidence production and specialty drug diffusion
Vakratsas, Demetrios; Wang, Wei-Lin - In: Journal of marketing 88 (2024) 1, pp. 116-137
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10014582836
Saved in:
Cover Image
The vaccine industry after the COVID-19 pandemic : an international perspective
Lobo, Félix - 2024
The purpose of this report is to analyze the impact that the COVID-19 pandemic has had on the vaccine industry from an international perspective. The objective is to learn from the experience and contribute to the design of better tools for future vaccine development and manufacturing, as we...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10014637110
Saved in:
Cover Image
Negotiating health and autonomy : data exclusivity, healthcare policies and access to pharmaceutical innovations
Menezes, Henrique Zeferino de; Paranhos, Julia; Torres, … - 2024
This paper analyzes the debate over the international dissemination of data exclusivity as a form of protection for clinical trial data. This is a critical demand for pharmaceutical companies seeking larger market shares and longer periods of monopoly in order to recover investments in research...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10014637112
Saved in:
Cover Image
Did the COVID-19 pandemic propel usage of AI in pharmaceutical innovation? : new evidence from patenting data
Rathi, Sawan; Majumdar, Adrija; Chatterjee, Chirantan - In: Technological forecasting and social change : an … 198 (2024), pp. 1-15
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015075658
Saved in:
Cover Image
Impact of hospital decision-making on drug markets : the case of biosimilars
Kanazawa, Kyogo - 2024
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015051304
Saved in:
Cover Image
Representation and extrapolation : evidence from clinical trials
Alsan, Marcella; Durvasula, Maya; Gupta, Harsh; … - In: The quarterly journal of economics 139 (2024) 1, pp. 575-635
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10014528129
Saved in:
Cover Image
Sustaining the integration of social objectives over time : a case-based analysis of access to medicine in the pharmaceutical industry
Bünder, Tobias; Rathert, Nikolas; Mair, Johanna - In: Business & society 63 (2024) 5, pp. 1110-1148
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10014577841
Saved in:
Cover Image
Compulsory licensing as a remedy against excessive pricing of life-saving medicines
Kianzad, Behrang - 2024
The COVID-19 crisis intensified decade-long debates on the interaction between intellectual property rights (IPRs), competition law and access to affordable life-saving treatments and vaccines. Compulsory licensing of patented medicines is a tried-and-tested method to expand access, particularly...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10014541546
Saved in:
Cover Image
Acquiring R&D projects: who, when, and what? : evidence from antidiabetic drug development
Malek, Jan; Newham, Melissa; Seldeslachts, Jo; … - 2024
This paper analyzes M&A patterns of R&D projects in the antidiabetics industry. For this purpose, we construct a database with all corporate individual antidiabetics R&D projects over the period 1997 - 2017, and add detailed information on firms' technology dimension using patent information,...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10014468769
Saved in:
Cover Image
Acquiring R&D projects: who, when, and what? : evidence from antidiabetic drug development
Malek, Jan; Newham, Melissa; Seldeslachts, Jo; … - 2024
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10014469053
Saved in:
Cover Image
Pharmaceutical innovation collaboration, evaluation, and matching
Liu, Qianshuo - In: Journal of health economics 98 (2024), pp. 1-21
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015182090
Saved in:
Cover Image
Funding of clinical trials and reported drug efficacy
Oostrom, Tamar - In: Journal of political economy 132 (2024) 10, pp. 3298-3333
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015144357
Saved in:
Cover Image
Using artificial intelligence to advance the research and development of orphan drugs
Irissarry, Carla; Burger-Helmchen, Thierry - In: Businesses 4 (2024) 3, pp. 453-472
While artificial intelligence has successful and innovative applications in common medicine, could its application facilitate research on rare diseases? This study explores the application of artificial intelligence (AI) in orphan drug research, focusing on how AI can address three major...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015098443
Saved in:
Cover Image
The role of Information Technology and employee engagement in enhancing Knowledge Management in the pharmaceutical Research and Development process : insights from dynamic capabilities theory
Chatzifoti, Natalia; Didaskalou, Eleni A.; Chountalas, … - In: Businesses 4 (2024) 3, pp. 315-330
This study investigates the impact of Information Technology and employee engagement on the implementation of Knowledge Management within the Research and Development processes of pharmaceutical companies. Based on Dynamic Capabilities Theory, this research examines the interaction between these...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015098513
Saved in:
Cover Image
Valuation of Regulatory Risk on Pharmaceutical R&D
Corzo Santamaría, Teresa; Portela, José; Schwartz, … - National Bureau of Economic Research - 2026
Geopolitical tensions, supply-chain concerns and policy risk have moved to the forefront of the pharmaceutical industry. This paper develops a real options valuation model of drug R&D that captures sequential clinical investment with technical failure, stochastic costs, uncertain cash flows, and...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015611167
Saved in:
Cover Image
From free rider to innovator : the rise of China's drug development
Barwick, Panle Jia; Xia, Hongyuan; Xia, Tianli - 2026
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015615578
Saved in:
Cover Image
Improving access to medicines and promoting pharmaceutical innovation
Gamba, Simona (contributor); Magazzini, Laura (contributor);  … - European Parliament / Directorate-General for … - 2023
Health is a fundamental human right, and achieving equal access to medicines is crucial to ensuring public health. The current system of pharmaceutical innovation relies strongly on the private sector, and remuneration of innovation is mainly based on exclusivities. This system presents several...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015279627
Saved in:
Cover Image
Potential measures to facilitate the productions of active pharmaceutical ingredients (APIs)
Fischer, Stefan (contributor); Knoll, Verena (contributor);  … - European Parliament / Directorate-General for Internal … - 2023
European countries have been experiencing medicine shortages due to disruptions in the supply chain. Reshoring the productions of active pharmaceutical ingredients (APIs) is considered as an approach to secure the supply. This study informs about the state-of-play of API production in the...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10015280407
Saved in:
Cover Image
Predicting Research and Development Costs for Pharmaceutical Projects : (Cost Reduction and Competitive Advantage Perspective)
ElNashar, Tamer Aly; T. ElNashar, Noha - 2023
In this paper, we present how to investigate the postulation for cost reduction and competitive advantage in industries similar to the pharmaceutical companies by analysing the research and development cost in those companies, where we predict this cost to be low if such postulations are...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10014346641
Saved in:
Cover Image
Effects of Trips Agreement on Indian Pharmaceutical Patenting
Pai, Rimpa - 2023
The TRIPS Agreement obligated India to amend its patent laws to meet the minimum standard of patent protection and patentability. In 2005, India amended its Patent Act to comply with TRIPS, which resulted in the removal of several provisions that facilitated the production and importation of...
Persistent link: https://www.econbiz.de, ebvufind01.dmz1.zbw.eu/10014347932
Saved in:
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • Next
  • Last
A service of the
zbw
  • Sitemap
  • Plain language
  • Accessibility
  • Contact us
  • Imprint
  • Privacy

Loading...